Antigenics Inc.

Antigenics Inc.
Search
Products and TechnologiesClinical TrialsNewsroomInvestorsJobsAbout Antigenics

Oncophage® patient-specific cancer vaccine

An investigational product

The Basics The Technology Clinical Experience Oncophage News

Oncophage news

Date Title (click to view the full text)
April 8, 2008Oncophage® Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
February 20, 2008Antigenics Announces Publication of Phase 3 Melanoma Study Results in Journal of Clinical Oncology
October 25, 2007Data From Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 10, 2007First Patient Registered in Investigator-Sponsored Phase 2 Trial of Antigenics’ Oncophage Cancer Vaccine in Glioma
August 2, 2007Antigenics Provides Update on Filing for Approval of Oncophage® in Russia for the Treatment of Intermediate-Risk Kidney Cancer
May 21, 2007Oncophage® Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer
April 16, 2007Data From Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
November 16, 2006Data From Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at Immunotherapy Task Force Meeting at the Society of Neuro-Oncology’s Annual Meeting
June 7, 2006Antigenics Announces Results From In-Depth Analysis of Phase 3 Data of Oncophage in Kidney Cancer and Provides Regulatory Update
June 5, 2006Antigenics Presents Phase 3 Data From Trial of Oncophage in Metastatic Melanoma at ASCO Meeting
March 24, 2006Antigenics Reports Phase 3 Results for Oncophage in Kidney Cancer
November 21, 2005First Patient Enrolled in Investigator-Sponsored Phase 1/2 Trial of Antigenics’ Oncophage Cancer Vaccine in Glioma
October 10, 2005Antigenics Announces Preliminary Survival Data From Its Randomized Phase 3 Metastatic Melanoma Trial
June 7, 2005Antigenics’ Oncophage Cancer Vaccine Receives European Orphan Drug Designation for Renal Cell Carcinoma
June 7, 2004Phase 3 Demographic Data on Antigenics’ Oncophage Cancer Vaccine in Kidney Cancer Published at ASCO Meeting
Antigenics home pageSitemap for antigenics.comGlossaryContact Antigenics